M 314
Pill imprint M 314 has been identified as Sotalol hydrochloride 160 mg.
Sotalol is used in the treatment of atrial fibrillation; atrial flutter; ventricular arrhythmia and belongs to the drug classes group III antiarrhythmics, non-cardioselective beta blockers. There is no proven risk in humans during pregnancy.
Sotalol 160 mg is not subject to the Controlled Substances Act.
See also related documents.
Sotalol hydrochloride Images
- Imprint:
-
M 314
- Strength:
- 160 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
FD&C Yellow No. 6 Lake
magnesium stearate
microcrystalline cellulose
pregelatinized corn starch
sodium lauryl sulfate
- Drug Class:
- Group III antiarrhythmics
Non-cardioselective beta blockers - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0314
Advertisement
More Sotalol Hydrochloride resources
- Sotalol (Wolters Kluwer)
- sotalol (Cerner Multum)
- sotalol AF (Cerner Multum)
- sotalol (Micromedex) - Includes Dosage Information
- sotalol Intravenous (Micromedex) - Includes Dosage Information
- Sotalol Hydrochloride (AHFS DI)
- Sotalol (FDA)
- Sotalol Injection (FDA)
- Sotalol Hydrochloride (Wolters Kluwer)
Search Again
